^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IO-106

    i
    Other names: IO-106
    Associations
    News
    Trials
    Company:
    Immune-Onc Therap
    Drug class:
    LAIR1 antagonist
    Related drugs:
    Associations
    News
    Trials